|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Device-associated infection rates, mortality, length of stay and bacterial resistance in intensive care units in Ecuador: International Nosocomial Infection Control Consortium's findings显示文摘AIM To report the results of the International Nosocomial Infection Control Consortium(INICC) study conducted in Quito, Ecuador.METHODS A device-associated healthcare-acquired infection(DAHAI) prospective surveillance study conducted from October 2013 to January 2015 in 2 adult intensive care units(ICUs) from 2 hospitals using the United States Centers for Disease Control/National Healthcare Safety Network(CDC/NHSN) definitions and INICC methods. RESULTS We followed 776 ICU patients for 4818 bed-days. The central line-associated bloodstream infection(CLABSI) rate was 6.5 per 1000 central line(CL)-days, the ventilator-associated pneumonia(VAP) rate was 44.3 per 1000 mechanical ventilator(MV)-days, and the catheterassociated urinary tract infection(CAUTI) rate was 5.7 per 1000 urinary catheter(UC)-days. CLABSI and CAUTI rates in our ICUs were similar to INICC rates [4.9(CLABSI) and 5.3(CAUTI)] and higher than NHSN rates [0.8(CLABSI) and 1.3(CAUTI)]- although device use ratios for CL and UC were higher than INICC and CDC/NSHN's ratios. By contrast, despite the VAP rate was higher than INICC(16.5) and NHSN's rates(1.1), MV DUR was lower in our ICUs. Resistance of A. baumannii to imipenem and meropenem was 75.0%, and of Pseudomonas aeruginosa to ciprofloxacin and piperacillin-tazobactam was higher than 72.7%, all them higher than CDC/NHSN rates. Excess length of stay was 7.4 d for patients with CLABSI, 4.8 for patients with VAP and 9.2 for patients CAUTI. Excess crude mortality in ICUs was 30.9% for CLABSI, 14.5% for VAP and 17.6% for CAUTI. CONCLUSION DA-HAI rates in our ICUs from Ecuador are higher than United States CDC/NSHN rates and similar to INICC international rates. | Estuardo Salgado Yepez Maria M Bovera Victor D Rosenthal Hugo A González Flores Leonardo Pazmino Francisco Valencia Nelly Alquinga Vanessa Ramirez Edgar Jara Miguel Lascano Veronica Delgado Cristian Cevallos Gasdali Santacruz Cristian Pelaéz Celso Zaruma Diego Barahona Pinto | 2017 | World Journal of Biological Chemistry2017，8，1： | 23 |
| 2 | 国际胃袖状切除专家共识:基于>12000手术病例的最佳操作指南显示文摘腹腔镜胃袖状切除术(1aparoscopic sleeve gastrectomy,LSG)系相对较新的减重手术方式。因其操作相对简单、治疗肥胖合并疾病及减重效果明显,逐步得以广泛接受。目前美国代谢与减重手术协会将其推荐为肥胖症治疗的单独标准术式。2011年3月25~26日, | 苏远涛 徐安安 朱江帆 Diaz AA Arvidsson D Baker RS Basso N Bellanger D Boza C El Mourad H France M Gagner M Galvao-Neto M Higa KD Himpens J Hutchinson CM Jacobs M Jorgensen JO Jossart G Lakdawala M Nguyen NT Nocca D Prager G Pomp A Ramos AC Rosenthal RJ Shah S Vix M Wittgrove A Zundel N | 2013 | 中国微创外科杂志2013，13，9： | 12 |
| 3 | Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops显示文摘 | Enders M Weidner A Rosenthal T | 2008 | J Infect Dis2008，197，1： | 1 |
| 4 | Mechanisms in the simultaneous aqueous extraction of oil and protein from soybean显示文摘 | ROSENTHAL A PYLE D L NIRANJAN K | 1998 | Transactions of the Institute of Chemical Engineers Part C Food and Bioproduets1998，76，： | 1 |
| 5 | Sonic hedgehog signaling by the pached-smoothened receptor complex显示文摘 | Murone M Rosenthal A de Sauvage FJ | 1999 | Curr Biol1999，9，2： | 1 |
| 6 | Photodynamic therapy in the treatment of cancer显示文摘 | His R A Rosenthal D I Glatstein E | 1999 | Drugs1999，57，： | 1 |
| 7 | Towards holistic 'front ends' in new product development显示文摘 | Khurana A Rosenthal S R | 1998 | Journal of Product Innovation Management1998，15，1： | 1 |
| 8 | Differential Regulation of beta-Defensin Expression in Human Skin by Microbial Stimuli显示文摘 | Sorensen O E Thapa D R Rosenthal A | 2005 | J Immunol2005，174，8： | 1 |
| 9 | Promotion of Central Cholinergic and do Paminergic neuron differentiation by neurotrophic-3显示文摘 | Knusel B Winslow JW Rosenthal A | 1991 | Proc Natl-acadsci USA1991，88，： | 1 |
| 10 | Photodynamic therapy in the treatment of cancer 显示文摘 | Hsi R A Rosenthal D I Glastein E | 1999 | Drugs1999，57，5： | 1 |
| 11 | Treatment of primary pulmonary hypertension with oral sildenafil 显示文摘 | Karatza A A Narang I Rosenthal M | 2004 | Respiration2004，71，2： | 1 |
| 12 | Screening for ovarian cancer显示文摘 | Rosenthal A N Menon U Jacobs I J | 2006 | Clin Obstet Gynecol2006，49，3： | 1 |
| 13 | Target coverage for head and neck cancers treated with IMRT:review of clinical experiences显示文摘 | GARDEN A S MORRISON W H ROSENTHAL D I | 2004 | Semin Radiat Oncol2004，14，2： | 1 |
| 14 | Combined effect of operational varia- bles and enzyme activity on aqueous enzymatic extraction of oil and protein from soybean 显示文摘 | Rosenthal A Pyle D L | 2008 | Enzyme and Microbial Technology2008，28，： | 1 |
| 15 | Device-associated noso eomial infection rates in intensive care units of seven Indian cities Findings of the International Nosocomial Infection Control Con sortium(INICC) 显示文摘 | Mehta A Rosenthal VD Mehta Y | 2007 | J Hosp Infect2007，67，2： | 1 |
| 16 | Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults显示文摘 | Breslau N Roth T Rosenthal L et a/ | 1996 | Biol Psychiatry1996，39，6： | 1 |
| 17 | The bronchial circulation--worth a closer look:a review of the relationship between the bronchial vasculature and airway inflammation显示文摘 | McCullagh A Rosenthal M Wanner A | 2010 | Pediatr Pulmonol2010，45，1： | 1 |
| 18 | Crisis Decision Making显示文摘 | HART P T U ROSENTHAL A KLUZMIN | 1993 | Administration & Society1993，25，1： | 1 |
| 19 | Toll - like receptor 9, CpG DNA and innate immunity 显示文摘 | ASHKAR A A ROSENTHAL K L | | Curr Mol Med0，2，6： | 1 |
| 20 | Cavitation of pulmonary metastases as aresponse to chemotherapy 显示文摘 | Thalinger A R Rosenthal S N Borg S | 1980 | Cancer1980，46，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员